14-day Premium Trial Subscription Try For FreeTry Free
NASDAQ:ALXN
Delisted

Alexion Pharmaceuticals Stock Price (Quote)

$182.50
+0 (+0%)
At Close: May 27, 2022

Range Low Price High Price Comment
30 days $182.50 $182.50 Friday, 27th May 2022 ALXN stock ended at $182.50. During the day the stock fluctuated 0% from a day low at $182.50 to a day high of $182.50.
90 days $182.50 $182.50
52 weeks $174.72 $187.45

Historical Alexion Pharmaceuticals prices

Date Open High Low Close Volume
Aug 20, 2018 $118.47 $118.47 $115.65 $116.17 1 342 684
Aug 17, 2018 $117.07 $117.28 $115.45 $116.00 1 109 413
Aug 16, 2018 $115.97 $118.33 $114.40 $117.28 1 410 453
Aug 15, 2018 $118.90 $118.90 $115.08 $115.32 1 807 140
Aug 14, 2018 $118.86 $120.61 $118.61 $119.68 880 659
Aug 13, 2018 $118.96 $119.99 $118.25 $118.37 1 256 718
Aug 10, 2018 $119.54 $119.97 $118.15 $118.88 1 027 326
Aug 09, 2018 $121.10 $121.40 $119.37 $120.14 1 421 354
Aug 08, 2018 $122.23 $122.39 $119.80 $120.34 1 677 089
Aug 07, 2018 $122.24 $123.34 $121.13 $122.40 1 705 012
Aug 06, 2018 $123.18 $123.70 $120.54 $123.36 1 930 169
Aug 03, 2018 $126.99 $128.00 $122.81 $123.67 2 495 530
Aug 02, 2018 $130.97 $131.43 $124.85 $126.01 3 143 521
Aug 01, 2018 $132.33 $133.72 $131.77 $132.99 1 284 252
Jul 31, 2018 $132.22 $133.47 $130.89 $132.96 1 482 026
Jul 30, 2018 $131.44 $132.45 $129.41 $131.51 1 596 156
Jul 27, 2018 $136.61 $136.90 $130.50 $131.83 2 464 076
Jul 26, 2018 $137.86 $138.77 $131.21 $136.51 2 462 208
Jul 25, 2018 $135.43 $137.62 $134.25 $137.18 1 405 363
Jul 24, 2018 $135.68 $137.33 $134.42 $135.30 1 320 357
Jul 23, 2018 $135.16 $135.17 $133.45 $134.58 1 200 355
Jul 20, 2018 $134.93 $135.78 $134.01 $135.16 1 425 193
Jul 19, 2018 $135.17 $135.86 $134.34 $135.09 1 301 406
Jul 18, 2018 $135.83 $135.97 $134.45 $135.65 977 556
Jul 17, 2018 $133.94 $137.90 $133.78 $136.40 1 543 322
Click to get the best stock tips daily for free!

About Alexion Pharmaceuticals

Alexion Pharmaceuticals Alexion Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes life-transforming therapeutic products. The company offers Soliris (eculizumab), a monoclonal antibody for the treatment of paroxysmal nocturnal hemoglobinuria (PNH), a genetic blood disorder; and atypical hemolytic uremic syndrome (aHUS), a genetic disease. It provides Strensiq (asfotase alfa), a targeted enzyme replacement therapy for patients with hypophosp... ALXN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT